These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 37234801)
1. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling. Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801 [TBL] [Abstract][Full Text] [Related]
2. Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes. Cui Y; Yuan Q; Chen J; Jiang J; Guan H; Zhu R; Li N; Liu W; Wang C Front Endocrinol (Lausanne); 2023; 14():1127441. PubMed ID: 37223030 [TBL] [Abstract][Full Text] [Related]
3. Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients. Liu J; Wu H; Wang Q; Jin S; Hou S; Shen Z; Zhao L; Xu S; Pang D Cancer Control; 2024; 31():10732748241288118. PubMed ID: 39340434 [TBL] [Abstract][Full Text] [Related]
4. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis. Tang M; Rong Y; Li X; Pan H; Tao P; Wu Z; Liu S; Tang R; Liu Z; Cai H BMC Cancer; 2024 Sep; 24(1):1163. PubMed ID: 39300389 [TBL] [Abstract][Full Text] [Related]
5. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer. Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271 [TBL] [Abstract][Full Text] [Related]
6. Identification of the Immune Subtypes for the Prediction of Metastasis in Pancreatic Neuroendocrine Tumors. Meng D; Zhao L; Liu J; Ge C; Zhang C Neuroendocrinology; 2023; 113(7):719-735. PubMed ID: 36871552 [TBL] [Abstract][Full Text] [Related]
7. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma. Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y Front Immunol; 2023; 14():1135617. PubMed ID: 37081871 [TBL] [Abstract][Full Text] [Related]
8. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma. Zhang X; Wen Z; Wang Q; Ren L; Zhao S Front Immunol; 2023; 14():1199869. PubMed ID: 37575253 [TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma. Liu Y; Shi Z; Zheng J; Zheng Z; Sun H; Xuan Z; Bai Y; Fu M; Du Y; Shao C Front Immunol; 2023; 14():1171883. PubMed ID: 37056778 [TBL] [Abstract][Full Text] [Related]
10. Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma. Qi L; Chen F; Wang L; Yang Z; Zhang W; Li ZH Front Pharmacol; 2023; 14():1136184. PubMed ID: 36937870 [No Abstract] [Full Text] [Related]
11. Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer. Li C; Weng J; Yang L; Gong H; Liu Z Front Immunol; 2024; 15():1378305. PubMed ID: 38779664 [TBL] [Abstract][Full Text] [Related]
12. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy. Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253 [TBL] [Abstract][Full Text] [Related]
13. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma. Wu Z; Zhang R; Bao J; Yin M; Wang X Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413 [TBL] [Abstract][Full Text] [Related]
14. A prognostic model for anoikis-related genes in pancreatic cancer. Song W; Hu H; Yuan Z; Yao H Sci Rep; 2024 Jul; 14(1):15200. PubMed ID: 38956290 [TBL] [Abstract][Full Text] [Related]
15. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer. Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300 [TBL] [Abstract][Full Text] [Related]
16. Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer. Chen G; Liu Y; Su D; Qiu J; Long J; Zhao F; Tao J; Yang G; Huang H; Xiao J; Zhang T; Zhao Y Cell Oncol (Dordr); 2023 Dec; 46(6):1691-1708. PubMed ID: 37434012 [TBL] [Abstract][Full Text] [Related]
17. An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration. Shi J; Peng B; Zhou X; Wang C; Xu R; Lu T; Chang X; Shen Z; Wang K; Xu C; Zhang L J Cancer Res Clin Oncol; 2023 Oct; 149(13):12089-12102. PubMed ID: 37421452 [TBL] [Abstract][Full Text] [Related]
18. Construction of a gene signature associated with anoikis to evaluate the prognosis and immune infiltration in patients with colorectal cancer. Wen H; Ni X; Qian S; Abdul S; Lv H; Chen Y Transl Cancer Res; 2024 Apr; 13(4):1904-1923. PubMed ID: 38737694 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer. Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507 [TBL] [Abstract][Full Text] [Related]
20. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer. Xiao Y; Zhou H; Chen Y; Liu L; Wu Q; Li H; Lin P; Li J; Wu J; Tang L Front Genet; 2023; 14():1186862. PubMed ID: 37323657 [No Abstract] [Full Text] [Related] [Next] [New Search]